Player FM 앱으로 오프라인으로 전환하세요!
Dr. Ingmar Gorman on Psychedelic-Assisted Psychotherapy
Manage episode 319126579 series 2911227
Dr. Ingmar Gorman is a Co-founder and Chief Executive Officer of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. As a psychologist, he shares his expertise in empirically supported psychedelic treatments with his clients and trainees alike. Dr. Gorman received his clinical training in New York City at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University. He simultaneously served as site co-principal investigator on an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and is currently a study therapist on the same study, as well as another FDA approved clinical trial of psilocybin for treatment resistant depression. Dr. Gorman has published on the topics of classic psychedelics, ketamine, MDMA, and Psychedelic Harm Reduction and Integration.
In this episode, Beth and Dr. Gorman discuss …
- Whether a psychedelic therapist needs to be licensed
- The lack of protective mechanisms for clients that seek psychedelic therapy from unlicensed people
- The power of being an integration support person
- Psilocybin as an effective treatment for multiple psychiatric “disorders”
- Spiritual bypassing in the psychedelic realm
- How healing happens in relationship - not in a self-help vacuum
Free Gifts!
155 에피소드
Dr. Ingmar Gorman on Psychedelic-Assisted Psychotherapy
Medicine for These Times: The Psychedelic Entrepreneur with Beth Weinstein
Manage episode 319126579 series 2911227
Dr. Ingmar Gorman is a Co-founder and Chief Executive Officer of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. As a psychologist, he shares his expertise in empirically supported psychedelic treatments with his clients and trainees alike. Dr. Gorman received his clinical training in New York City at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University. He simultaneously served as site co-principal investigator on an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and is currently a study therapist on the same study, as well as another FDA approved clinical trial of psilocybin for treatment resistant depression. Dr. Gorman has published on the topics of classic psychedelics, ketamine, MDMA, and Psychedelic Harm Reduction and Integration.
In this episode, Beth and Dr. Gorman discuss …
- Whether a psychedelic therapist needs to be licensed
- The lack of protective mechanisms for clients that seek psychedelic therapy from unlicensed people
- The power of being an integration support person
- Psilocybin as an effective treatment for multiple psychiatric “disorders”
- Spiritual bypassing in the psychedelic realm
- How healing happens in relationship - not in a self-help vacuum
Free Gifts!
155 에피소드
Toate episoadele
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.